Period for regain compliance. Period For Regain Compliance Period for regain compliance Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative Document Transition Report Document Transition Report Outstanding as of December 31, 2022 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Money Market [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Stock option vesting period Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Grants Receivable, Current Grant receivable Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Total unamortized compensation cost related to outstanding unvested stock options and restricted stock awards Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Issuance of common stock for in process research and development (in shares) Stock Issued During Period, Shares, Issued for Services Debt principal repayment start date. Debt Principal Repayment Start Date Debt principal repayment start date Operating Lease, Liability, Noncurrent Noncurrent operating lease liability Stock Repurchased During Period, Shares Number of stock repurchased Lorem Vascular, Pte. Ltd. Lorem Vascular Pte Ltd [Member] Lorem Vascular Pte Ltd [Member] Schedule of Stock by Class [Table] Schedule Of Stock By Class [Table] Piramal pharma solutions inc. Piramal Pharma Solutions Inc [Member] Piramal Pharma Solutions, Inc. [Member] Class of Stock [Line Items] Class of Stock [Line Items] Cash paid during period for: Cash Paid During Period For [Abstract] Cash paid during period for: Assets, Current Total current assets Liabilities and Equity Total liabilities and stockholders’ equity Entity Address, State or Province Entity Address, State or Province Litigation Case [Domain] Litigation Case Two thousand eighteen rights offering. Two Thousand Eighteen Rights Offering [Member] 2018 Rights Offering [Member] Issue and sale of stock, net Stock Issued During Period, Value, New Issues Sale of common stock, net Two thousand and twenty two purchase agreement. Two Thousand and Twenty Two Purchase Agreement [Member] 2022 Purchase Agreement [Member] Stock split conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Outstanding as of September 30, 2023 (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Outstanding as of December 31, 2022 (in shares) Trading Symbol Trading Symbol Common Stock, Shares, Issued Common stock, shares issued (in shares) Preferred stock, voting rights Preferred Stock, Voting Rights Interest Rate Floor [Member] Interest Rate Floor [Member] Rights related to distribution of assets Rights Related To Distribution Of Assets Rights related to distribution of assets. Percentage of grant proceeds with interest not exceed annually. Percentage Of Grant Proceeds With Interest Not Exceed Annually Percentage of grant proceeds with interest not exceed annually Lease Expiration Date Operating leases, expiration date Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Table] Shares, Outstanding Balance (in shares) Balance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Number of shares reserved for issuance and sale Common stock capital shares reserved for future issuance Long-Term Debt, Current Maturities Term loan obligation, current Long-Term Debt, Current Maturities, Total Term loan obligation Entity Address, City or Town Entity Address, City or Town Class of Warrant or Right, Outstanding Class of warrant outstanding Lessee, Operating Lease, Renewal Term Lessee, operating lease, renewal term Debt Disclosure [Text Block] Term Loan Obligations Vested and exercisable as of September 30, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Subsequent Event [Member] Subsequent Event Subsequent Event Type [Axis] Common stock, sales, available for issuance. Common Stock Sales Available For Issuance Remaining availability under financing facility Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Liabilities, Current [Abstract] Current liabilities: Assets, Current [Abstract] Current assets: Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Statement of Stockholders' Equity [Abstract] License agreement abstract. License Agreement [Abstract] Change in accounting principle, accounting standards update, immaterial effect Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false] Vested and expected to be vested as of September 30, 2023 (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Operating Lease, Liability, Current Operating lease liability Less: current portion Second amendment to the amended and restated loan and security agreement. Term Loan [Member] Term Loan [Member] Debt Instrument, Maturity Date Maturity date Derivative Contract [Domain] Derivative Contract Property, Plant and Equipment, Net Property and equipment, net Property, Plant and Equipment, Net, Total Equity incentive plans. Equity Incentive Plans [Member] Equity Incentive Plans [Member] Class of Stock [Domain] Class of Stock Investment Income, Interest Interest income Vested and expected to be vested as of September 30, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Entity Central Index Key Entity Central Index Key Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of shares callable by warrants (in shares) Number of securities called by warrant or right Plan Name [Domain] Plan Name Change in accounting principle, accounting standards update, adopted Change in Accounting Principle, Accounting Standards Update, Adopted [true false] Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Loss on disposal of property and equipment Fair Value Assets, Fair Value Disclosure Assets, Fair Value Disclosure, Total Lessee, Operating Lease, Option to Extend Lessee, operating lease, option to extend Preferred Stock, Shares Outstanding Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding, Ending Balance Series F Preferred Stock [Member] Series F Preferred Stock [Member] Liabilities, Current Total current liabilities Entity Tax Identification Number Entity Tax Identification Number Regain compliance expiry date Regain Compliance Expiry Date Regain compliance expiry date. Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Increase (Decrease) in Operating Capital [Abstract] Increases (decreases) in cash caused by changes in operating assets and liabilities: New Accounting Pronouncements or Change in Accounting Principle [Line Items] September two thousand and twenty two distribution agreement. September Two Thousand and Twenty Two Distribution Agreement [Member] September 2022 Distribution Agreement [Member] Financial Instruments [Domain] Financial Instruments Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Weighted Average Remaining Contractual Life (years) [Roll Forward] Grant [Member] Grant [Member] Maximum value of shares to be issued under agreement. Maximum Value of Shares to be Issued Under Agreement Maximum value of shares to be issued under agreement Services agreement. Services Agreement [Member] Services Agreement [Member] Plan Name [Axis] Plan Name Derivative Instrument [Axis] Derivative Instrument Lessee, Operating Lease, Term of Contract Lessee, operating lease, term of contract Assets Total assets Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Common Class A [Member] Common Class A [Member] Entity Registrant Name Entity Registrant Name Stock based compensation 2015 equity incentive plan 1 member. Stock Based Compensation2015 Equity Incentive Plan1 [Member] 2015 Plan [Member] Lessee, Operating Lease, Existence of Option to Extend [true false] Lessee, operating lease, existence of option to extend [true false] Related Party, Type [Domain] Related Party Recorded Unconditional Purchase Obligation [Line Items] Recorded Unconditional Purchase Obligation [Line Items] Accumulated deficit Retained Earnings (Accumulated Deficit) Accumulated deficit Retained Earnings (Accumulated Deficit), Total Canaccord Genuity L L C [Member] Canaccord Genuity LLC [Member] Supplemental Cash Flow Information [Abstract] Supplemental disclosure of cash flows information: Charlottesville Charlottesville [Member] Charlottesville [Member] Retained Earnings [Member] Accumulated Deficit [Member] Liabilities, Fair Value Adjustment Change in fair value of liability instruments Class of Stock [Axis] Class of Stock Minimum [Member] Minimum [Member] Revenues, Total Revenues Revenue Revenue recognized Lease liability Operating Lease, Liability Present value of obligations under leases Equity Component [Domain] Equity Component Change in accounting principle, accounting standards update, adoption date Change in Accounting Principle, Accounting Standards Update, Adoption Date Disclosure of accounting policy for license agreement. License Agreement Disclosure [Text Block] License Agreements Amortization of Debt Issuance Costs and Discounts Amortization of deferred financing costs and debt discount Amortization of Debt Issuance Costs and Discounts, Total Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Measurement Frequency [Axis] Options. Options [Member] Outstanding Stock Options [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price [Roll Forward] Debt Disclosure [Abstract] Debt Instrument, Basis Spread on Variable Rate Basis variable rate Entity Current Reporting Status Entity Current Reporting Status Common Stock, Shares Authorized Common stock, shares authorized (in shares) Research and development expense Research and Development Expense Research and development Research and Development Expense, Total Fair Value, by Balance Sheet Grouping [Table] Fair Value By Balance Sheet Grouping [Table] Stock Repurchase Program, Authorized Amount Authorized amount of repurchase of stock Share-Based Payment Arrangement, Activity [Table Text Block] Stock Option Activity Assets [Abstract] Assets Proceeds from sale of common stock, net of offering cost of $0.2 million and $0.7 million, respectively Proceeds from Issuance of Common Stock Proceeds from sale of common stock, net Revenue from Contract with Customer [Policy Text Block] Grant Receivable and Revenue Recognition Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Securities remaining and available for future issuances (in shares) Convertible Preferred Stock [Member] Convertible Preferred Stock [Member] Common stock, $0.001 par value; 100,000,000 shares authorized; 4,522,656 and 2,240,092 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively Voting stock, value Common Stock, Value, Issued Debt Instrument, Offering Date Origination date Principal payments of term loan obligation Repayments of Long-Term Debt Repayments of Long-Term Debt, Total Vested and exercisable as of September 30, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Payment for tech transfer and validation fee Payment For Tech Transfer And Validation Fee Payment for tech transfer and validation fee. Current Fiscal Year End Date Current Fiscal Year End Date Lincoln park capital fund, LLC. Lincoln Park Capital Fund L L C [Member] Lincoln Park Capital Fund, LLC [Member] Share-Based Payment Arrangement, Noncash Expense Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense, Total Operating Income (Loss) Loss from operations Consideration paid to preferred stock holders Consideration Paid To Preferred Stock Holders Consideration paid to preferred stock holders. Use of Estimates [Abstract] Use Of Estimates [Abstract] Loan and security agreement. Loan And Security Agreement [Member] Loan and Security Agreement [Member] Increase decrease in grant receivable. Increase Decrease In Grant Receivable Grant Receivable Refers to the period exercisable from the date of issuance. Period Exercisable From The Date Of Issuance Period exercisable from the date of issuance Disaggregation of Revenue [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Stock option vesting percentage Consecutive business days. Consecutive Business Days Consecutive business days Change in operating lease liabilities Increase (Decrease) in Operating Lease Liability Contract effective date. Contract Effective Date Contract effective date Revenue from Contract with Customer [Text Block] Grant Revenue Outstanding as of September 30, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Principal and final payment loan amount Debt Instrument, Face Amount Original loan amount UTHSCSA License Agreement [Member] U T H S C S A License Agreement [Member] UTHSCSA license agreement member. Sale of Stock, Price Per Share Sale of Stock, Price Per Share Operating Expenses [Abstract] Operating expenses: Commitments and Contingencies Disclosure [Abstract] Other Assets, Noncurrent Other assets Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Common stock shares to be issued (in shares) Granted (in shares) Equity [Text Block] Stockholders' Equity Interest Paid, Excluding Capitalized Interest, Operating Activities Interest Liquidity Abstract Liquidity [Abstract] Initial commitment shares. Initial Commitment Shares Initial commitment shares Sale of the japanese subsidiary and certain assets. Sale Of Japanese Subsidiary And Certain Assets [Member] Sale of the Japanese Subsidiary and Certain Assets [Member] Additional Paid in Capital Additional paid-in capital Additional Paid in Capital, Total Common Class B [Member] Common Class B [Member] Vested and exercisable as of September 30, 2023 Vested and expected to be vested as of September 30, 2023 (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Equity, Attributable to Parent [Abstract] Stockholders’ equity: Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Entity [Domain] Entity Earnings Per Share [Abstract] Offering cost Offering Costs Offering costs. Litigation Case [Axis] Litigation Case Contract termination date. Contract Termination Date Contract termination date Consideration to purchaser in cash Sale of Stock, Consideration Received on Transaction Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Earnings Per Share, Basic Net loss per share, basic Earnings Per Share, Basic, Total Commitments and Contingencies Commitments and contingencies (Note 8) Income Statement [Abstract] Related Party, Type [Axis] Related Party Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total Grant funding term. Grant Funding Term Grant funding term Increase (decrease) in grant revenue. Increase (Decrease) in Grant Revenue Increase in grant revenue Vested and expected to be vested as of September 30, 2023 (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Statistical Measurement [Domain] Statistical Measurement Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net cash used in operating activities Document Period End Date Document Period End Date Statistical Measurement [Axis] Statistical Measurement Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Stockholders' Equity Note [Abstract] Earnings Per Share, Diluted Net loss per share, diluted Earnings Per Share, Diluted, Total Product and Service [Domain] Minimum liquidity covenant amount. Minimum Liquidity Covenant Amount Minimum liquidity covenant Reimbursement costs incurred. Reimbursement Costs Incurred Identified eligible reimbursable costs Revenue from Contract with Customer [Abstract] Stock Redeemed or Called During Period, Shares Redemption of Series F preferred stock (in shares) Redemption of Series F preferred stock (in shares) Debt Instrument, Name [Domain] Debt Instrument, Name Fair Value Hierarchy and NAV [Domain] Recurring Basis [Member] Fair Value, Recurring [Member] LIBOR [Member] LIBOR [Member] LIBOR. Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Options [Roll Forward] Representative Series U Warrant. Representative Series U Warrant [Member] Representative Warrants [Member] Initial commitment fee. Initial Commitment Fee Initial commitment fee paid in cash Aggregate expense including fee and disbursement expenses. Aggregate Expense Including Fee and Disbursement Expenses Reimburse of fee and disbursements expenses Series F Convertible Preferred Stock [Member] Series F Convertible Preferred Stock. Liabilities and Equity [Abstract] Liabilities and Stockholders’ Equity Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Interactive Data Current Entity Interactive Data Current Common stock issued in payment for in process research and development Stock Issued Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Share based compensation arrangement by share based payment award options aggregate intrinsic value. Share Based Compensation Arrangement by Share Based Payment Award Options Aggregate Intrinsic Value [Abstract] Aggregate Intrinsic Value [Roll Forward] Equity Components [Axis] Equity Components Nano Tx license agreement Member Nano Tx Licenses Agreement [Member] Nano Tx Licenses Agreement [Member] Accounting Standards Update and Change in Accounting Principle [Text Block] Recently Issued Accounting Pronouncements Liquidity and Going Concern Disclosure Of Liquidity And Going Concern Text Block Disclosure of liquidity and going concern text block Percentage issuance of common stock. Percentage Issuance Of Common Stock Percentage issuance of common stock Local Phone Number Local Phone Number Sale of Stock [Axis] Sale of Stock Operating leases, expiry year. Operating Leases Expiry Year Operating leases expiry year Goodwill Goodwill Goodwill, Total Goodwill, Beginning Balance Goodwill, Ending Balance Statement of Cash Flows [Abstract] Percentage of non-dilutive monetary awards required to pay Percentage of Non-dilutive Monetary awards Required to Pay Percentage of non-dilutive monetary awards required to pay. Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block] Fair Value Measurements Series C convertible preferred stock. Series C Convertible Preferred Stock [Member] Series C Convertible Preferred Stock [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Contractual obligation to provide funding of research and development costs over periods that initially exceed one year or the normal operating cycle, if longer. Pre Clinical Research Study Obligations [Member] Pre-clinical Research Study Obligations [Member] Debt Instrument, Interest Rate, Stated Percentage Interest rate Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average period for recognition of cost Vested and expected to be vested as of September 30, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Maximum [Member] Maximum [Member] Option for exclusive worldwide license Option For Exclusive Worldwide License Option for exclusive worldwide license. Outstanding warrants and options. Outstanding Warrants and Options [Member] Outstanding Warrants and Options [Member] Series B convertible preferred stock. Series B Convertible Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Level 3 [Member] Fair Value, Inputs, Level 3 [Member] APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total Fair Value, Recurring and Nonrecurring [Table] Change in fair value of derivative instruments Fair Value Adjustment of Warrants Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect January two thousand and twenty two distribution agreement. January Two Thousand and Twenty Two Distribution Agreement [Member] January 2022 Distribution Agreement [Member] Percentage of aggregate amount of proceeds awarded under CPRIT grant. Percentage Of Aggregate Amount Of Proceeds Awarded Under CPRIT Grant Percentage of aggregate amount of proceeds awarded under CPRIT grant Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Cancelled/forfeited (in shares) Number Of Votes Per Share Number of votes per share. Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Antidilutive Securities Excluded from Diluted Income (Loss) per Share Closing bid price for common stock had fallen. Closing Bid Price For Common Stock Had Fallen Below Closing bid price for common stock had fallen below Payments for Royalties License fee payment in cash City Area Code City Area Code Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows used in operating activities: Sale closed date Sale of Stock, Transaction Date Resale of up to an additional stock Resale of Stock Resale of stock. General and Administrative Expense General and administrative General and Administrative Expense, Total Weighted Average Number of Shares Outstanding, Basic Basic weighted average shares used in calculating net loss per share attributable to common stockholders Weighted Average Number of Shares Outstanding, Basic, Total CPRIT grant funding term. CPRIT Grant Funding Term CPRIT grant funding term, description Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Statement [Table] Statement [Table] Document Fiscal Period Focus Document Fiscal Period Focus Long term debt outstanding threshold amount. Long Term Debt Outstanding Threshold Amount Long term debt outstanding threshold amount Statement [Line Items] Statement [Line Items] Master services agreement Terms description. Master Services Agreement Terms Description Master services agreement terms, Description Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Dilutive common shares excluded from the calculations of diluted loss per share (in shares) Twenty twenty purchase agreement. Twenty Twenty Purchase Agreement [Member] 2020 Purchase Agreement [Member] Warrant [Member] Outstanding Warrants [Member] Number of warrants exercised Number Of Warrants Exercised Number of warrants exercised Deferred grant liability Increase Decrease In Deferred Grant Liability Increase (decrease) in deferred grant liability. Common Stock [Member] Common Stock [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Distribution agreement member. Distribution Agreement [Member] 2020 Distribution Agreement [Member] Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Other Assets, Current Other current assets Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Government contracts and other. Government Contracts and Other [Member] ASU 2016-13 Accounting Standards Update 2016-13 [Member] Cover [Abstract] Document Fiscal Year Focus Document Fiscal Year Focus Number of maximum common shares can be resale. Number of Maximum Common Shares Can Be Resale Number of maximum common shares can be resale Litigation Settlement, Expense Litigation settlement, expense Sale of Stock [Domain] Sale of Stock Preferred Stock [Member] Preferred Stock [Member] Convertible Preferred Stock [Member] Medidata solutions, inc. Medidata Solutions Inc [Member] Medidata Solutions, Inc. [Member] Security Exchange Name Security Exchange Name Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Stock option contractual term Accounting Standards Update and Change in Accounting Principle [Table] Preferred Stock, Shares Issued Preferred stock, shares issued (in shares) Preferred Stock, Shares Authorized Preferred stock, shares authorized (in shares) Right-of-use assets acquired by assuming operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Cancelled/forfeited (in dollars per share) At the market offering program. At The Market Offering Program [Member] At The Market Offering Program [Member] Legal Entity [Axis] Legal Entity Financial Instrument [Axis] Financial Instrument Warrants and Rights Outstanding, Term Warrants expected term Payments for Loans Payments for principal, interest and fees Entity Emerging Growth Company Entity Emerging Growth Company Amendment Flag Amendment Flag Payments to Acquire Intangible Assets Purchases of intangible assets Purchase of intangible assets Reverse stock split effective date. Reverse Stock Split Effective Date Reverse stock split effective date Accounting Standards Update [Domain] Basis of Accounting, Policy [Policy Text Block] Basis of Presentation and New Accounting Standards Shares issued Shares, Issued Remaining common stock issued and sold (in shares) Variable Rate [Domain] Variable Rate Securities Act File Number Entity File Number Vested and exercisable as of September 30, 2023 Vested and exercisable as of September 30, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Long-Term Debt, Excluding Current Maturities Term loan obligation Long-Term Debt, Excluding Current Maturities, Total Biocept Agreement [Member] Biocept Agreement [Member] Biocept Agreement. Recorded Unconditional Purchase Obligation [Table] Recorded Unconditional Purchase Obligation [Table] Share-Based Payment Arrangement [Abstract] Deferred grant liability Deferred Income, Noncurrent Disposal Group Classification [Domain] Disposal Group Classification Accrued payments due to NanoTx Accrued License Payable Accrued license payable. Debt Instrument [Axis] Debt Instrument Operating Expenses Total operating expenses Other Intangible Assets, Net Intangible assets, net Stockholders' Equity, Reverse Stock Split Reverse stock split Entity Address, Address Line Two Entity Address, Address Line Two Preferred Stock, Value, Issued Preferred stock, $0.001 par value; 5,000,000 shares authorized; 1,952 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively Entity Small Business Entity Small Business Entity Shell Company Entity Shell Company Sold shares under first registration statement Sale of Stock, Number of Shares Issued in Transaction Investment Type [Axis] Investment Type Class of Warrant or Right, Exercise Price of Warrants or Rights Warrant exercise price (in dollars per share) Gross proceeds from issuance of common stock. Gross Proceeds from Issuance of Common Stock Aggregate gross proceeds from sales of common stock Class of Warrant or Right [Domain] Class of Warrant or Right Earnings Per Share [Text Block] Loss per Share Series U warrants member Series U Warrants [Member] Series U Warrants [Member] Entity Address, Address Line One Entity Address, Address Line One Contractual Obligation Contractual obligation Contractual Obligation, Total Stock issued for research and development Stock Issued for Research and Development Stock issued for research and development. Subsequent Event Type [Domain] Amortization of Debt Discount (Premium) Non-cash amortization Sales order term. Sales Order Term Sales order term Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Fractional adjustment of common stock. Fractional Adjustment of Common Stock Fractional adjustment Share Price Closing price per share Master services agreement date. Master Services Agreement Date Master service agreement date Depreciation, Depletion and Amortization Depreciation and amortization Depreciation, Depletion and Amortization, Total Product and Service [Axis] Master services agreement initial term. Master Services Agreement Initial Term Master services agreement initial term Stock Issued During Period, Shares, Stock Splits Common stock, reverse stock split, fractional shares issued | shares Percentage of commission on gross proceeds from sale of common stock. Percentage of Commission on Gross Proceeds from Sale of Common Stock Percentage of commission on gross proceeds from sale of common stock Title of 12(b) Security Title of 12(b) Security Cash paid for IPRD asset acquired in an asset acquisition. Cash Paid For I P R D Asset Acquired In An Asset Acquisition In process research and development acquired Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Investments [Domain] Investments Accounting Standards Update [Axis] Subscription and Investment Representation Agreement Subscription Agreement [Member] Subscription Agreement [Member] Provides an entity's explanation that the preparation of financial statements in conformity with generally accepted accounting principles requires the use of management estimates. Use Of Estimates [Text Block] Use of Estimates Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows used in investing activities: Unpaid Offering Costs. Unpaid Offering Costs Unpaid offering cost Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current, Total Cash and Cash Equivalents [Axis] Common Stock, Shares, Outstanding Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding, Ending Balance Share-Based Payment Arrangement [Text Block] Stock-based Compensation Operating lease discount rate Lessee, Operating Lease, Discount Rate Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted (in dollars per share) Document Type Document Type Debt Instrument, Fee Amount Fees amount associated with loan Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Document Quarterly Report Document Quarterly Report Disposal Group Classification [Axis] Disposal Group Classification Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Entity Filer Category Entity Filer Category Number Of Preferred Stock Shares Exercised. Number Of Preferred Stock Shares Exercised Number of preferred stock, shares converted Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental schedule of non-cash investing and financing activities: Recorded Unconditional Purchase Obligation by Category of Item Purchased [Axis] Recorded Unconditional Purchase Obligation by Category of Item Purchased Other assets Increase (Decrease) in Other Noncurrent Assets Variable Rate [Axis] Variable Rate Nonoperating Income (Expense) Total other income (expense) Liabilities Total liabilities Equity, Attributable to Parent Balance Balance Total stockholders’ equity Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] SOFR [Member] Stock Issued During Period, Shares, Reverse Stock Splits Stock issued during period reverse stock splits, shares Net Income (Loss) Net loss Net loss Interest Expense Interest expense Interest expense Interest Expense, Total Cash and Cash Equivalents [Domain] Statement of Financial Position [Abstract] Basis of Presentation and Significant Accounting Policies [Text Block] Basis of Presentation and New Accounting Standards Weighted Average Number of Shares Outstanding, Diluted Diluted weighted average shares used in calculating net loss per share attributable to common stockholders Weighted Average Number of Shares Outstanding, Diluted, Total Amortization of operating lease right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Other Income and Expenses [Abstract] Other income (expense): Use of Estimates, Policy [Policy Text Block] Use of Estimates Issuance of common stock for in process research and development Stock Issued During Period, Value, Issued for Services Outstanding as of September 30, 2023 (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding as of December 31, 2022 (in dollars per share) Unconditional Purchase Obligation, Category of Goods or Services Acquired [Domain] Unconditional Purchase Obligation, Category of Goods or Services Acquired Floating interest rate for funds borrowed, under the debt agreement. Debt Instrument Floating Interest Rate Percentage Interest rate Cancer prevention and research institute of texas contract. Cancer Prevention And Research Institute Of Texas Contract [Member] CPRIT Contract [Member] Disaggregation of Revenue [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Fair Value Disclosures [Abstract] Fair Value Hierarchy and NAV [Axis] Measurement Frequency [Domain] Stock based compensation 2020 equity incentive plan. Stock Based Compensation2020 Equity Incentive Plan [Member] 2020 Plan [Member] Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment, Total Issue and sale of share Stock Issued During Period, Shares, New Issues Common stock issued (in shares) Warrants issued, underwritten public offering, period. Warrants Issued Underwritten Public Offering Period Warrants issued, underwritten public offering, period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Debt Instrument, Covenant Compliance Debt instrument, covenant compliance Class of Warrant or Right [Axis] Class of Warrant or Right Accounting Standards Update and Change in Accounting Principle [Abstract]